Nova Patents
NO982249L

Platelet aggregation inhibitors

Abstract

The present invention relates to a process for the preparation of a purified platelet aggregation inhibiting agent (VAG) comprising a fibrinogen / fibrinogen / Willebrandt factor GP IIb-IIIa termination enhancer and a vitreous nectin binding to vitrinoceptin receptor or a fibrin genes by fibrinogen receptor reflux viscous VAG-spun. It is also an object of the present invention to provide a recombinant agent for the production of a required nucleic acid sequence for the construction of vector cells and host cells. ŕ

Term

No projected expiry on record.

  1. Priority
  2. Published
  3. Filed
  4. Today

64 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
36750989United States of AmericaA
41802889United States of AmericaA
48322990United States of AmericaA
9003417United States of AmericaW
9003417–––
36750989–––
41802889–––
48322990–––
US19890367509–––
US19890418028–––
US19900483229–––
WO1990US03417–––

Members64

Family members, oldest first
DocumentOfficeKind
CA2059124A1CanadaA1
CA2388770A1CanadaA1
WO9015620A1World Intellectual Property Organization (WIPO)A1
AU6036990AAustraliaA
NO914962D0NorwayD0
NO914962LNorwayL
NO982249LThis recordNorwayL
HU905490D0HungaryD0
EP0477295A1European Patent Office (EPO)A1
HUT59835AHungaryA
KR920702627ARepublic of KoreaA
EP0477295A4European Patent Office (EPO)A4
JPH05500750AJapanA
AU636159B2AustraliaB2
US5318899AUnited States of AmericaA
US5344783AUnited States of AmericaA
US5496724AUnited States of AmericaA
EP0477295B1European Patent Office (EPO)B1
EP0751219A1European Patent Office (EPO)A1
AT146969TAustriaT
DE69029579D1GermanyD1
ES2097150T3SpainT3
DK0477295T3DenmarkT3
DE69029579T2GermanyT2
US5686566AUnited States of AmericaA
US5686567AUnited States of AmericaA
US5686568AUnited States of AmericaA
US5686569AUnited States of AmericaA
US5686570AUnited States of AmericaA
US5686571AUnited States of AmericaA
US5736339AUnited States of AmericaA
NO982249D0NorwayD0
US5756451AUnited States of AmericaA
US5759999AUnited States of AmericaA
US5770564AUnited States of AmericaA
US5780595AUnited States of AmericaA
US5786333AUnited States of AmericaA
US5795867AUnited States of AmericaA
US5795868AUnited States of AmericaA
US5807825AUnited States of AmericaA
US5807828AUnited States of AmericaA
NO304267B1NorwayB1
US5843897AUnited States of AmericaA
US5851839AUnited States of AmericaA
KR0180918B1Republic of KoreaB1
HU216318BHungaryB
US5935926AUnited States of AmericaA
US5958732AUnited States of AmericaA
US5968902AUnited States of AmericaA
FI104364BFinlandB
NL990043I1Netherlands (Kingdom of the)I1
LU90488I2LuxembourgI2
DE19975072I1GermanyI1
NL990043I2Netherlands (Kingdom of the)I2
RU2156468C2Russian FederationC2
JP3281370B2JapanB2
NO312965B1NorwayB1
CA2059124CCanadaC
EP0477295B2European Patent Office (EPO)B2
DK0477295T4DenmarkT4
NO2000008I2NorwayI2
ES2097150T5SpainT5
DE69029579T3GermanyT3
DE19975072I2GermanyI2